Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors Backbone

Condition:   HIV-1 Infection Intervention:   Other: Samplings Sponsors:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   ViiV Healthcare Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials

Related Links:

We previously reported that four doses or four double doses of hepatitis B vaccination regimens could not significantly increase a response rate compared with standard doses. However, the antibody levels were ...
Source: AIDS Research and Therapy - Category: Infectious Diseases Authors: Tags: Short Report Source Type: research
ConclusionsDespite being on ART, a significant proportion of HIV/HBV-coinfected individuals present HBV viremia. Characterization of factors that are associated with this finding may help professionals provide better management to these patients.
Source: The Brazilian Journal of Infectious Diseases - Category: Infectious Diseases Source Type: research
Condition:   Hepatitis C Virus Infection Interventions:   Behavioral: Behavioural intervention;   Diagnostic Test: HCV RNA home-based test Sponsors:   Public Health Service of Amsterdam;   ZonMw: The Netherlands Organisation for Health Research and Development;   Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC);   The National Institute for STI and Aids Control in the Netherlands (Soa Aids Nederland);   Julius Centre for Health Sciences and Primary Care, UMC Utrecht Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conclusion SD remain frequent in HIV-HCV coinfected patients and are associated with a series of modifiable behavioural risk factors. Independent of HCV cure, improved screening and comprehensive management of alcohol use, physical and psychological self-reported symptoms and depression are essential in this population. Closer investigation of these risk factors of SDs may both increase sleep quality and indirectly improve patients’ clinical outcomes.
Source: European Journal of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
Notice from the Centers for Disease Control and Prevention extending the comment period for an earlier notice making revisions to an information collection related to the Resources and Services Database of the CDC National Prevention Information Network (NPIN). NPIN serves as the reference and referral service for information on HIV/AIDS, hepatitis, sexually transmitted diseases, and tuberculosis. Comments are due by within 30 days of this notice.
Source: Federal Register updates via the Rural Assistance Center - Category: Rural Health Source Type: news
AIDS Research and Human Retroviruses, Ahead of Print.
Source: AIDS Research and Human Retroviruses - Category: Infectious Diseases Authors: Source Type: research
Authors: Vuylsteke B, Reyniers T, De Baetselier I, Nöstlinger C, Crucitti T, Buyze J, Kenyon C, Wouters K, Laga M Abstract INTRODUCTION: Pre-Exposure Prophylaxis (PrEP) is highly effective in reducing the risk for HIV infection among men who have sex with men (MSM) and may have an important impact in slowing down the HIV epidemic. Concerns remain however about low adherence, increased risk behaviour and reduced condom use when using PrEP. The aim of this study was to assess these factors prospectively among MSM using daily and event-driven PrEP in Belgium. METHODS: An open-label prospective cohort study wa...
Source: Journal of the International AIDS Society - Category: Infectious Diseases Tags: J Int AIDS Soc Source Type: research
Condition:   Tuberculous Meningitis Interventions:   Drug: Aspirin;   Drug: Placebo of aspirin;   Drug: WHO TBM treatment;   Drug: Intensified TBM treatment Sponsors:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   European Union;   European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: France Health | Hepatitis | HIV AIDS | Research | Virology